Objectives of the Study:
# To define and measure the global Electroceuticals Market with respect to product, type of device, application, end user and region
# To identify key micromarkets and their drivers within the global electroceuticals/bioelectric medicine market, which are expected to show growth opportunities in the coming years
# To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
# To analyze the market structure and profile the key players of the global electroceuticals medicine market and comprehensively analyze their core competencies
# To track and analyze competitive developments such as product launches, approvals, agreements/collaborations/joint ventures/partnerships, marketing and promotion activities, acquisitions and mergers, expansions, new program launches, and product enhancements
Research Methodology:
Top-down and bottom-up approaches were used to validate the size of the global electroceuticals market and estimate the size of various other dependent submarkets. Individual bottom-up approach was followed for Implantable Cardioverter Defibrillators and Cardiac Pacemakers Market, Cochlear Implants Market, Retinal Implants Market, and Neuromodulation Devices Market to arrive at the Global Electroceuticals/ Bioelectric Medicine Market Size.
Various secondary sources such as directories, industry journals, databases such as Hoover’s, Bloomberg Business, Factiva, and Avention, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.
Get the Sample Pages@ http://bit.ly/2ViyuzL
On the basis of region, the electroceuticals market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. The large share of the North American region can be attributed to the rising prevalence of arrhythmia, growing prevalence of chronic diseases, high prevalence of hearing loss, expected approvals for retinal implants in the U.S., conferences & annual meetings held in the U.S., increasing regulatory approvals in the U.S., increasing burden of cancer and diabetes, and increase in hearing loss owing to rising aging population in Canada. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period (2016-2021).
The major players in electroceuticals market include Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), Cochlear Limited (Australia), Sonova Holding AG (Switzerland), LivaNova PLC (U.K.), Biotronik (Germany), Nevro Corporation (U.S.), Second Sight Medical Products, Inc. (U.S.), and ElectroCore LLC (U.S.). Others are BioElectronics Corporation (U.S.), MED-EL (Austria), Cefaly Technology (Belgium), Stimwave LLC (U.S.), Vomaris Innovations, Inc. (U.S.), EnteroMedics Inc. (U.S.), NeuroSigma, Inc. (U.S.), and Oticon Medical (France).
Target Audience:
# Electroceutical/Bioelectric Medicine Device Manufacturing Companies
# Suppliers and Distributors of Electroceutical/Bioelectric Medicine Devices
# Healthcare Service Providers
# Teaching Hospitals and Academic Medical Centers (AMCs)
# Health Insurance Players
# Research and Consulting Firm
# Medical Research Institutes
# Audiology Centers
# Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
# Venture Capitalists
# Community Centers
You Can Also Talk to Our Research Experts for More Detailed Information@ http://bit.ly/2Svl7ub
Scope of the Report:
This research report categorizes the market into the following segments and subsegments:
Electroceuticals Market, by Product
- Implantable Cardioverter Defibrillators
- Cardiac Pacemakers
- Spinal Cord Stimulators
- Cochlear Implants
- Deep Brain Stimulators
- Transcutaneous Electrical Nerve Stimulators
- Vagus Nerve Stimulators
- Sacral Nerve Stimulators
- Retinal Implants
- Other Electrical Stimulators
Electroceuticals Market, by Type of Device
- Implantable Electroceutical Devices
- Non-Invasive Electroceutical Devices
Electroceuticals Market, by Application
- Cardiac Pacemakers And Implantable Cardioverter Defibrillators Applications
- Arrhythmia
- Spinal Cord Stimulators Applications
- Chronic Pain
- Failed Back Surgery
- Ischemia
- Cochlear Implants Applications
- Sensorineural hearing loss
- Deep Brain Stimulators Applications
- Parkinson’s Disease
- Tremor
- Depression
- Other Deep Brain Stimulation Applications
- Transcutaneous Electrical Nerve Stimulators Applications
- Treatment Resistant Depression
- Other Transcutaneous Electrical Nerve Stimulator Applications
- Vagus Nerve Stimulators Applications
- Epilepsy
- Other Vagus Nerve Stimulation Applications
- Sacral Nerve Stimulators Applications
- Urinary Incontinence
- Fecal Incontinence
- Retinal Implants Applications
- Retinitis Pigmentosa
- Other Electrical Stimulators Applications
- Gastroparesis
- Obesity
- Depression
- Migraine
- Spinal Cord Injury
Electroceuticals Market, by End User
- Hospitals
- Research Institutes
- Individual Users
Electroceuticals Market, by Region
- North America
- U.S.
- Canada
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Read More@
https://www.marketsandmarkets.com/Market-Reports/electroceutical-market-222053956.html